Mesoblast Ltd Files 6-K Report

Ticker: MEOBF · Form: 6-K · Filed: Oct 7, 2025 · CIK: 1345099

Mesoblast LTD 6-K Filing Summary
FieldDetail
CompanyMesoblast LTD (MEOBF)
Form Type6-K
Filed DateOct 7, 2025
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, foreign-private-issuer, corporate-disclosure

Related Tickers: MESO

TL;DR

MESO filed a 6-K with the SEC on Oct 7, 2025, standard foreign issuer report.

AI Summary

On October 7, 2025, Mesoblast Limited filed a new release announcement with the Australian Securities Exchange. This filing is a Form 6-K report for the month of October 2025, indicating its status as a foreign private issuer. The company is incorporated in Australia and its CEO is Silviu Itescu.

Why It Matters

This filing provides an update on Mesoblast Limited's regulatory activities and corporate disclosures to the SEC, relevant for investors tracking the company's compliance and reporting.

Risk Assessment

Risk Level: low — This filing is a routine report of a foreign private issuer and does not contain significant new financial or operational information.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The Form 6-K filing is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of October 2025.

When was the announcement filed with the Australian Securities Exchange?

Mesoblast Limited filed a new release announcement with the Australian Securities Exchange on October 7, 2025.

Who is the Chief Executive Officer of Mesoblast Limited?

Silviu Itescu is the Chief Executive Officer and Executive Director of Mesoblast Limited.

Where is Mesoblast Limited incorporated?

Mesoblast Limited is incorporated in Australia.

What is the company's fiscal year end?

The company's fiscal year end is June 30.

Filing Stats: 212 words · 1 min read · ~1 pages · Grade level 17.3 · Accepted 2025-10-06 20:09:51

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Paul Hughes Paul Hughes Company Secretary Dated October 7, 2025 INDEX TO EXHIBITS Item 99.1 Press release of Mesoblast Ltd, dated October 7, 2025.

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing